Literature DB >> 9129076

Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection.

G Robin1, D Cohen, N Orr, I Markus, R Slepon, S Ashkenazi, Y Keisari.   

Abstract

The IgG subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide (LPS) was examined in subjects naturally exposed to these organisms. Affinity-purified LPS antibodies obtained using a column of Shigella LPS bound to epoxy-activated Sepharose 6B were used as standards to calibrate the serum antibody response to natural Shigella infection. The geometric mean concentrations of specific IgG in sera from those not exposed to Shigella organisms were 7.9 microg/mL against S. sonnei LPS and 18.6 microg/mL against S. flexneri 2a LPS. After natural exposure to S. sonnei or S. flexneri 2a, the concentrations rose to 30.3 and 127.9 microg/mL, respectively. IgG2 was the major component in the anti-S. flexneri subclass response, while the anti-S. sonnei response was dominated by IgG1. High levels of IgG1 antibodies before exposure to organisms from either Shigella serogroup correlated with a lower risk of developing symptomatic infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129076     DOI: 10.1086/516452

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T.

Authors:  J Wei; M B Goldberg; V Burland; M M Venkatesan; W Deng; G Fournier; G F Mayhew; G Plunkett; D J Rose; A Darling; B Mau; N T Perna; S M Payne; L J Runyen-Janecky; S Zhou; D C Schwartz; F R Blattner
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 2.  Serum IgG antibodies to Shigella lipopolysaccharide antigens - a correlate of protection against shigellosis.

Authors:  Dani Cohen; Shiri Meron-Sudai; Anya Bialik; Valeria Asato; Sophy Goren; Ortal Ariel-Cohen; Arava Reizis; Amit Hochberg; Shai Ashkenazi
Journal:  Hum Vaccin Immunother       Date:  2019-05-09       Impact factor: 3.452

3.  Thymic independence of adaptive immunity to the intracellular pathogen Shigella flexneri serotype 2a.

Authors:  S S Way; A C Borczuk; M B Goldberg
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

4.  Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.

Authors:  Shannon J Heine; Jovita Diaz-McNair; Abhay U Andar; Cinthia B Drachenberg; Lillian van de Verg; Richard Walker; Wendy L Picking; Marcela F Pasetti
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

Review 5.  Tissues: the unexplored frontier of antibody mediated immunity.

Authors:  Nicholas E Webb; Biana Bernshtein; Galit Alter
Journal:  Curr Opin Virol       Date:  2021-02-10       Impact factor: 7.090

6.  An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei.

Authors:  Mariaelena Caboni; Thierry Pédron; Omar Rossi; David Goulding; Derek Pickard; Francesco Citiulo; Calman A MacLennan; Gordon Dougan; Nicholas R Thomson; Allan Saul; Philippe J Sansonetti; Christiane Gerke
Journal:  PLoS Pathog       Date:  2015-03-20       Impact factor: 6.823

7.  Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study.

Authors:  Avital A Shimanovich; Amanda D Buskirk; Shannon J Heine; William C Blackwelder; Rezwanul Wahid; Karen L Kotloff; Marcela F Pasetti
Journal:  Clin Vaccine Immunol       Date:  2017-02-06

8.  Outer membrane proteins analysis of Shigella sonnei and evaluation of their antigenicity in Shigella infected individuals.

Authors:  Hemavathy Harikrishnan; Kirnpal Kaur Banga Singh; Asma Ismail
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

9.  A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge.

Authors:  Esther Ndungo; Arlo Randall; Tracy H Hazen; Dane A Kania; Krista Trappl-Kimmons; Xiaowu Liang; Eileen M Barry; Karen L Kotloff; Subhra Chakraborty; Sachin Mani; David A Rasko; Marcela F Pasetti
Journal:  mSphere       Date:  2018-08-01       Impact factor: 4.389

10.  A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.

Authors:  Christina W Obiero; Augustin G W Ndiaye; Antonella Silvia Sciré; Bonface M Kaunyangi; Elisa Marchetti; Ann M Gone; Lena Dorothee Schütte; Daniele Riccucci; Joachim Auerbach; Allan Saul; Laura B Martin; Philip Bejon; Patricia Njuguna; Audino Podda
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.